Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120859363 | 12085936 | 3 | F | 201503 | 20160830 | 20160217 | 20160902 | EXP | CA-PFIZER INC-2015167344 | PFIZER | 55.00 | YR | F | Y | 0.00000 | 20160902 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120859363 | 12085936 | 1 | SS | ENBREL | ETANERCEPT | 1 | 50 MG, UNK | N | 0 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 120859363 | 12085936 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | USUAL DOSE }3MONTH | N | 11719 | ||||||||||
| 120859363 | 12085936 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | N | 7073 | ||||||||||
| 120859363 | 12085936 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | USUAL DOSE }3MONTHS | N | 0 | TABLET | |||||||||
| 120859363 | 12085936 | 5 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | USUAL DOSE }3MONTH | N | 0 | TABLET | |||||||||
| 120859363 | 12085936 | 6 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | USUAL DOSE }3MONTH | N | 0 | |||||||||
| 120859363 | 12085936 | 7 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | USUAL DOSE }3MONTH | N | 0 | |||||||||
| 120859363 | 12085936 | 8 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | N | 0 | ||||||||||
| 120859363 | 12085936 | 9 | C | ARAVA | LEFLUNOMIDE | 1 | UNK | 0 | TABLET | ||||||||||
| 120859363 | 12085936 | 10 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 120859363 | 12085936 | 11 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 120859363 | 12085936 | 12 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 120859363 | 12085936 | 13 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | UNK | 0 | |||||||||||
| 120859363 | 12085936 | 14 | C | ORENCIA | ABATACEPT | 1 | UNK | 0 | |||||||||||
| 120859363 | 12085936 | 15 | C | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120859363 | 12085936 | 1 | Rheumatoid arthritis |
| 120859363 | 12085936 | 2 | Rheumatoid arthritis |
| 120859363 | 12085936 | 3 | Rheumatoid arthritis |
| 120859363 | 12085936 | 4 | Rheumatoid arthritis |
| 120859363 | 12085936 | 5 | Rheumatoid arthritis |
| 120859363 | 12085936 | 6 | Rheumatoid arthritis |
| 120859363 | 12085936 | 7 | Rheumatoid arthritis |
| 120859363 | 12085936 | 8 | Rheumatoid arthritis |
| 120859363 | 12085936 | 14 | Rheumatoid arthritis |
| 120859363 | 12085936 | 15 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120859363 | 12085936 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120859363 | 12085936 | Drug ineffective | |
| 120859363 | 12085936 | Drug intolerance | |
| 120859363 | 12085936 | Extremity contracture | |
| 120859363 | 12085936 | Psoriasis | |
| 120859363 | 12085936 | Pustular psoriasis | |
| 120859363 | 12085936 | Rheumatoid arthritis | |
| 120859363 | 12085936 | Scar |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120859363 | 12085936 | 1 | 20140822 | 0 |